Cholagogues and Choleretics
"Cholagogues and Choleretics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic).
Descriptor ID |
D002756
|
MeSH Number(s) |
D27.505.954.483.508
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cholagogues and Choleretics".
Below are MeSH descriptors whose meaning is more specific than "Cholagogues and Choleretics".
This graph shows the total number of publications written about "Cholagogues and Choleretics" by people in this website by year, and whether "Cholagogues and Choleretics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2000 | 1 | 0 | 1 |
2001 | 1 | 1 | 2 |
2002 | 2 | 0 | 2 |
2004 | 1 | 0 | 1 |
2005 | 1 | 2 | 3 |
2006 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2012 | 1 | 1 | 2 |
2016 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
2019 | 0 | 2 | 2 |
2020 | 0 | 2 | 2 |
2023 | 0 | 2 | 2 |
2024 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholagogues and Choleretics" by people in Profiles.
-
Primary biliary cholangitis. Lancet. 2024 Sep 14; 404(10457):1053-1066.
-
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis. N Engl J Med. 2024 Feb 29; 390(9):783-794.
-
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. N Engl J Med. 2024 Feb 29; 390(9):795-805.
-
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology. 2023 08 01; 78(2):397-415.
-
Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2021 07; 66(7):2439-2451.
-
Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study. BMC Complement Med Ther. 2020 Aug 01; 20(1):242.
-
Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol. 2020 Jan; 7(1):e61-e72.
-
The challenges of primary biliary cholangitis: What is new and what needs to be done. J Autoimmun. 2019 12; 105:102328.
-
Erythropoietic Protoporphyria: Initial Diagnosis With Cholestatic Liver Disease. Pediatrics. 2018 04; 141(Suppl 5):S445-S450.
-
Cross-Sectional Analysis of Progressive Familial Intrahepatic Cholestasis in Puerto Rican Children. P R Health Sci J. 2016 Dec; 35(4):220-223.